biotech medications

The Colombian Biological Medicines Decree

Por: Lina María Díaz Vera - Abogada, Asistente de Investigación

The Colombian Biotechnology Decree, enacted on September 18th[1], is part of Colombian competitiveness policy to attract investment and to exploit biodiversity in a sustainable way[2]. The Decree addresses two main issues: the requirements and procedure for the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) to evaluate biological medications [...]